Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Spinler, Jennifer K; Ross, Caná L; Savidge, Tor C

Spinler, Jennifer K; Ross, Caná L; Savidge, Tor C.

Afiliação

Spinler JK; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, 1102 Bates Ave., Houston, TX, USA; Department of Pathology & Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA. Electronic address: spinler@bcm.edu.
Ross CL; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, 1102 Bates Ave., Houston, TX, USA; Department of Pathology & Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
Savidge TC; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, 1102 Bates Ave., Houston, TX, USA; Department of Pathology & Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.

Anaerobe ; 41: 51-57, 2016 Oct.

Article em En | MEDLINE | ID: mdl-27180657

Assuntos

Clostridioides difficile/fisiologia; Enterocolite Pseudomembranosa/prevenção & controle; Probióticos/uso terapêutico; Animais; Ensaios Clínicos como Assunto; Transplante de Microbiota Fecal; Microbioma Gastrointestinal; Humanos

Palavras-chave

Bio-K+; Clostridium difficile; Fecal microbiota transplantation; Lactobacillus; Lifeway kefir; Probiotic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enterocolite Pseudomembranosa / Clostridioides difficile / Probióticos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google